FCRL4 and juvenile polyposis syndrome: In all, 28 previously described potential PJI biomarkers and three novel potential biomarkers, including CCL20, coagulation factor F7, and Fc receptor-like 4 (FCRL4), were elevated in PJI compared to NIAF [214].